Cargando…
Genetic Engineering of Klebsiella pneumoniae ATCC 25955 for Bioconjugate Vaccine Applications
Vaccination is considered the most effective means to fight against the multidrug-resistant strains of Klebsiella pneumoniae. In recent years, a potential protein glycan coupling technology has been extensively used in the production of bioconjugated vaccines. Here, a series of glycoengineering stra...
Autores principales: | Liu, Yan, Li, Shulei, Guo, Yan, Li, Xin, Zhu, Li, Wang, Hengliang, Wu, Jun, Pan, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222708/ https://www.ncbi.nlm.nih.gov/pubmed/37317295 http://dx.doi.org/10.3390/microorganisms11051321 |
Ejemplares similares
-
Genome Sequence of Klebsiella pneumoniae Strain ATCC 25955, an Oxygen-Insensitive Producer of 1,3-Propanediol
por: Wang, Yu, et al.
Publicado: (2013) -
A bioconjugate vaccine against Brucella abortus produced by engineered Escherichia coli
por: Li, Shulei, et al.
Publicado: (2023) -
A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae
por: Feldman, Mario F., et al.
Publicado: (2019) -
Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry
por: Mo, Mengting, et al.
Publicado: (2023) -
Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli
por: Liu, Yan, et al.
Publicado: (2023)